Indeed, we observed the substantially increased sensitivity to CPT in ESCC cells lacking SND1 expression (Figure 9C), suggesting that KDM6A–SND1 probably regulate drug sensitivity in a coordinated manner. This evidence concerns the gene SND1 and esophageal squamous cell carcinoma.